Events Search and Views Navigation

Event Views Navigation

Filters

Changing any of the form inputs will cause the list of events to refresh with the filtered results.

Current

    • BioVie Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease ahead of Topline Data in 2Q26

    Join BioVie Inc. for a virtual key opinion leader (KOL) event featuring Suzanne de la Monte, MD, MPH (Brown University Warren…
    TIME: 2:00 PM EDT
    LOCATION: Virtual
    View Details

    Trevi Therapeutics In-Person and Virtual Investor and Analyst Event to Discuss the Company’s Clinical and Commercial Strategy, Featuring KOLs in Chronic Cough

    Please join Trevi Therapeutics for its Investor and Analyst Day in Midtown, New York. During the program, Trevi's leadership team…
    TIME: 10:00 AM EDT
    LOCATION: Midtown, New York and Live Webcast
    View Details

    Perspective Therapeutics Analyst Event

    Please join Perspective Therapeutics for an in-person and virtual Analyst Event in New York, where the Company will share an…
    TIME: 8:30 AM EDT
    LOCATION: New York Stock Exchange (NYSE), 11 Wall St, New York, NY 10005
    View Details

    Eupraxia Pharmaceuticals Virtual Investor Event at DDW 2026 to Discuss EP-104GI and Unmet Needs In The Prevention of Esophageal Strictures

    Join Eupraxia Pharmaceuticals for a virtual investor event at Digestive Disease Week (DDW) held May 2-5, 2026, in Chicago, Illinois.…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    Eupraxia Pharmaceuticals In-Person and Virtual Investor Event at DDW 2026 to Discuss EP-104GI and Unmet Needs In The Prevention of Esophageal Strictures

    Join Eupraxia Pharmaceuticals for an in-person and virtual investor event at Digestive Disease Week (DDW) held May 2-5, 2026, in…
    TIME: 8:00 AM EDT
    LOCATION: Marriott Marquis Chicago, 2121 S Prairie Ave, Chicago, IL 60616
    View Details

    • Sagimet Biosciences – A Novel Mechanism of Action for Treating Acne: Update on the Planned Phase 3 Trial of Denifanstat for the Treatment of Moderate to Severe Acne for the US

    Join Sagimet Biosciences for a virtual event featuring key opinion leader (KOL) Julie Harper, MD, Founding Director and past President…
    TIME: 2:00 PM EDT
    LOCATION: Virtual
    View Details

    Alterity Therapeutics Virtual KOL Event to Review and Share New Insights on ATH434 for the Treatment of Multiple System Atrophy

    Join Alterity Therapeutics for a virtual key opinion leader (KOL) event featuring Roy Freeman, MD (Harvard Medical School, Beth Israel Deaconess…
    TIME: 1:00 PM EDT
    LOCATION: Virtual
    View Details

    Humacyte Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients

    Join Humacyte for a virtual key opinion leader (KOL) event featuring Prabir Roy-Chaudhury MD, PhD, FASN (University of North Carolina…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    MeiraGTx Holdings Virtual KOL Event: Long-term data presentation for AAV-hAQP1 program for the treatment of Grade 2/3 Radiation-Induced Xerostomia

    The event will provide the full 3-year data from all cohorts of the open label Phase 1 study of MeiraGTx's…
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    IDEAYA Biosciences Topline Results from Phase 2/3 OptimUM-02 Trial in Metastatic Uveal Melanoma

    Details to follow.
    TIME: 8:00 AM EDT
    LOCATION: Virtual
    View Details

    ProQR Therapeutics Virtual Investor Event: Expanding the Axiomer™ RNA Editing Opportunity Beyond AX-0810

    Ahead of the anticipated target engagement data for AX-0810 in the first half of 2026, the Company will showcase ProQR’s…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    Cue Biopharma – Virtual R&D Day Event to Discuss CUE-401, the Company’s Lead Asset for the Treatment of Autoimmune and Inflammatory Diseases

    Join Cue Biopharma for a virtual R&D Day Event featuring Richard DiPaolo, PhD (Saint Louis University) and Jonathan Kay, MD, FACP, MACR…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    Akebia Therapeutics Virtual R&D Day Highlighting Robust Kidney Disease Pipeline

    Join Akebia Therapeutics for a virtual R&D Day featuring scientific experts James A. Tumlin, MD (NephroNet), V. Michael Holers, MD (University of…
    TIME: 10:00 AM EDT
    LOCATION: Virtual
    View Details

    • Alumis Virtual KOL Event to Discuss the Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting

    Join Alumis for a virtual key opinion leader (KOL) event featuring leading dermatology and psoriasis expert Dr. Andrew Blauvelt, who will join…
    TIME: 7:00 PM EDT
    LOCATION: Virtual
    View Details

    Picard Medical Annual Business Update Featuring KOLs and Patient Testimonial

    Join Picard Medical/SynCardia for a virtual business update featuring key opinion leaders (KOLs) Amy Fiedler, MD (Associate Professor of Surgery, Surgical…
    TIME: 4:30 PM EDT
    LOCATION: Virtual
    View Details

    Talphera Virtual Investor & Analyst Event to Discuss NIYAD for Use in Continuous Renal Replacement Therapy (CRRT)

    Join Talphera for a virtual investor and analyst event featuring Blaithin McMahon, PhD, MBBChr (Medical University of South Carolina) and…
    TIME: 11:00 AM EDT
    LOCATION: Virtual
    View Details